erythema migrans

Trials

1,220 participants · First posted Dec 13, 2017

Completed

NCT03956212

Inflammatory Mediators in Erythema Migrans

150 participants · First posted May 20, 2019

Completed

NCT01475708

Doxycycline in Therapy of Erythema Migrans

400 participants · First posted Nov 21, 2011

Drugs

View all 13 →

Small Molecule

Approved

Thiabendazole

Manufacturer: Merck and co inc

C₁₀H₇N₃S

Small Molecule

Approved

Thalidomide(Thalomid, Thalidomide BMS (previously Thalidomide Celgene), Thalidomide Lipomed)

Conditions: Aphthous Stomatitis, Chronic Graft-Versus-Host Disease +9 more

C₁₃H₁₀N₂O₄ · Rx

Small Molecule

Approved

Brimonidine(Alphagan, Combigan, Lumify, Mirvaso, Onreltea, Qoliana, Simbrinza)

Manufacturer: Allergan inc, Allergan +7 more

Conditions: Increased Intra Ocular Pressure (IOP), Ocular Hypertension +1 more

C₁₁H₁₀BrN₅ · Rx

Organizations

TIGRAN TECHNOLOGIES AB

Spain

News

View all 218 →

7 months ago

En Carta Diagnostics Receives FDA Breakthrough Device Designation for Revolutionary Lyme Disease Test

11 years ago

PLEASE Trial Assesses Prolonged Antibiotic Treatment for Persistent Lyme Symptoms

last year

Trials

Erythema Migrans in Elderly

Inflammatory Mediators in Erythema Migrans

Doxycycline in Therapy of Erythema Migrans

Drugs

Thiabendazole

Thalidomide(Thalomid, Thalidomide BMS (previously Thalidomide Celgene), Thalidomide Lipomed)

Brimonidine(Alphagan, Combigan, Lumify, Mirvaso, Onreltea, Qoliana, Simbrinza)

Organizations

TIGRAN TECHNOLOGIES AB

News

En Carta Diagnostics Receives FDA Breakthrough Device Designation for Revolutionary Lyme Disease Test

PLEASE Trial Assesses Prolonged Antibiotic Treatment for Persistent Lyme Symptoms

Study Reveals Critical Gaps in Lyme Disease Follow-Up Care and Diagnostic Testing